Medicine

Meijie Yu, Hang Zhou, Xinyan Ma, Huilin Xia, Hong Zhang, Yuan Lu, Hongbo Chen, R. Yu, Yifan Wang, Peng Huang

2026.3.1Infectious Medicine

DOI: 10.1016/j.imj.2026.100252

Abstract

Highlights • Risks of liver cancer and death persist after antiviral cure.• Rising AFP and FIB-4 levels strongly predict adverse outcomes.• Continuous monitoring improves long-term risk assessment.

Citation format

YU, Meijie, et al. Repeated measurements of alpha fetoprotein and fibrosis-4 predict long term hepatocellular carcinoma and mortality risks after antiviral therapy. Infectious Medicine, 2026, 5(2): 100252.